ARNILA

Across TCGA pan-cancer cohorts, ARNILA RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated ARNILA data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ARNILA RNA is associated with better overall survival. In most high-consensus cancer types, elevated ARNILA expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, KIRC, and LIHC are the cancer types where ARNILA RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Quartile	All	0.681	0.505	.001	96	view →
KIRC	DFS	Tertile	All	0.775	0.864	<.001	94	view →
LIHC	OS	Tertile	All	0.574	0.774	<.001	70	view →
MESO	DFS	Median	II,III,IV	0.275	0.467	.002	66	view →
HNSC	OS	Tertile	All	0.838	0.703	.001	64	view →
ACC	DFS	Quartile	All	0.428	0.879	.007	52	view →
PAAD	DFS	Tertile	All	0.590	0.232	.001	35	view →
BRCA	OS	Quartile	All	0.639	0.503	.003	23	view →
SKCM	DFS	Median	All	0.783	0.689	.003	19	view →
LGG	OS	Tertile	All	0.640	0.465	.001	19	view →
READ	OS	Median	II,III,IV	1.000	0.848	.008	15	view →
CHOL	DFS	Tertile	All	0.809	0.125	.004	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

ARNILA–BLCA (OS)

Open the BLCA breakdown →